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Summary 
Endothelial cells regulate vascular tone by secreting paracrine mediators that control the contractility 
of arterial smooth muscle cells.  Nitric oxide (NO) is an important vasodilating agent that is 
generated from t-arginine by the enzyme nitric oxide synthase (NOS),  which is  expressed 
constitutively by the endothelium. NO also inhibits platelet aggregation, contributing to the 
antithrombotic properties of the endothelial surface.  It would therefore be expected that loss 
of the endothelium during arterial injury would lead to vasospasm and thrombosis but instead, 
the neointima formed after injury has a nonthrombogenic surface and a maintained vascular patency. 
We report here that arterial smooth muscle cells in the neointima formed after a deendothelializing 
balloon injury to the rat carotid artery express the cytokine-inducible isoform of NOS. Expression 
was detectable by reverse transcription-polymerase chain reaction from day 1-14 after injury and 
in situ hybridization showed expression of NOS mRNA by neointimal smooth muscle cells, 
particularly at the surface of the lesion. This was associated  with systemically detectable NO 
production as revealed by electron paramagnetic resonance spectroscopic analysis of nitrosylated 
red cell hemoglobin. Local NO production by intimal smooth muscle cells after endothelial injury 
could represent an important mechanism for the maintenance of arterial patency and nonthrom- 
bogenicity in the injured artery. 
N 
'itric oxide (NO) is a short-lived messenger molecule 
that is formed from r-arginine by the enzyme, NO syn- 
thase (NOS; EC 1.14.13.39)  (1, 2). Three isoforms of NOS 
have been isolated, cloned, and expressed from cellular sources 
(3-11).  NO formed by constitutively expressed endothelial 
NOS (eNOS) acts as a paracrine regulator of vascular tone 
by relaxing smooth muscle cells (SMC) (12, 13). NO is also 
an inhibitor ofplatelet aggregation (1, 2) and may contribute 
to the nonthrombogenic properties of the vascular surface. 
An inducible form of NOS (iNOS) is expressed in macro- 
phages and several other cell types including vascular SMC 
after stimulation with the cytokines, IFN-% TNF, and IL-1, 
or with LPS  (5-8,  14-16). 
Deendothelializing vascular injury elicits a tissue response 
that is characterized by platelet adhesion and aggregation, 
leukocyte infiltration, smooth muscle migration and prolifer- 
ation, and the formation of a neointima (17, 18). This may 
lead to arterial stenosis, which frequently occurs after human 
angioplasty (19). It is, however, remarkable that the denuded 
artery rapidly regains its nonthrombogenic properties and that 
the damaged arterial segment can be enlarged to compensate 
for the increased intimal thickness (20). 
It has recently been shown that cytokine-stimulated SMC 
in vitro express high levels of iNOS and produce significant 
amounts of NO (14-16)  and that deendothelialized arteries 
in  vivo  develop a  relaxing capacity that  is  dependent on 
t-arginine and augmented by IL-1,  compatible with an in- 
duction of iNOS in SMC (21). These observations suggest 
that SMC may be induced to express NOS in vivo after in- 
jury. We have tested this hypothesis by analyzing NOS mRNA 
and activity after deendothelializing injury to the carotid ar- 
tery of the rat. Our results indicate that iNOS is rapidly in- 
duced in neointimal smooth muscle cells after arterial injury. 
This may represent a mechanism for maintaining patency and 
nonthrombogenicity in injured blood vessels. 
Materials and Methods 
Animals and Surgical Procedures.  Arterial injury was inflicted in 
the common carotid artery of 5-mo-old Sprague Dawley rats (ob- 
tained from Alab, Stockholm, Sweden) with a Fogarty 2F balloon 
catheter (American Edwards Laboratory, Anasco, Puerto Rico) as 
described (22). In one group of rats, a balloon catheter was used 
to deendothelialize  the thoracic aorta. Another group was subjected 
to a sham operation in which a skin incision and dissection of the 
carotid artery but no deendothdialization was performed. Rats (n 
=  4  per group)  were killed by exsanguination  under fluniso- 
nium/fentanyl anesthesia at 24 h, 3, 7, and 14 d after surgery. All 
animal experiments were approved by the ethical committee of 
Gothenburg University. 
Cell Culture.  Smooth muscle cells were isolated from the aorta 
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scribed (23). Cells of the fourth to sixth passage were used for ex- 
periments. 
RNA Isolation.  The common carotid artery was rapidly chilled, 
dissected free from adventitia, and frozen in liquid nitrogen.  The 
tissue  was  homogenized  with  a  Polytron  tissue  homogenizer 
(InterMed, ILoskilde,  Denmark) and total RNA isolated using the 
method of Chomczynski  and Sacchi (24). 
Reverse Transc@tion  (RT) and PCR Amplification.  200 ng ILNA 
was incubated with 2.5 mM random hexamers, 1 mM of  each dNTP, 
2.5 U/ml Moloney routine leukemia virus RT (Boehringer Mann- 
heim, Mannheim, Germany), 1 U/ml RNasin (Boehringer Mann- 
heim), and 5 mM MgC12 in 20/~1 of RT buffer (50 mM KC1, 10 
mM Tris-HC1, pH 8.3) at 42~  for 20 min.  After denaturation 
at 99~  for 5 rain, the synthesized cDNA was subjected to a 35- 
cycle PCR. The 5' antisense primer corresponded to nucleotides 
2698-2720 of the murine macrophage  iNOS cDNA sequence,  (5-7), 
and the 3' sense primer to nucleotides 2941-2963. For comparison, 
B-actin transcripts were PCR-amplified from the same tissue ILNA 
using a commercial  primer set (Clontech, Palo Alto, CA). The PCR 
mix contained 20 pmol of each primer, 200 mM of each dNTP, 
and 2.5 U Taq polymerase (AmpliTaq; Perkin-Elmer Cetus, Nor- 
walk,  CT) in  100 #1 of RT buffer with 2 mM MgC12. 
Southern Blot.  PCR products were transferred from agarose  gels 
to nitrocellulose membranes (Hybond C extra; Amersham Inter- 
national, Little Chalfort,  UK) and hybridized with a 32p-labeled 
antisense  oligonucleotide  probe  corresponding  to  nucleotides 
2749-2778 of the murine iNOS (5-7) in 6 x  SSC, 5 x  Denhardt's 
solution,  and 0.1% SDS at 42~  The membranes were washed 
at 55~  in 0.5x  SSC, 0.1%  SDS. 
Construction of  Hybridization Prom  Cultured rat aortic SMC were 
treated with recombinant IFN-3, and TNF-c~, both at 500 U/ml 
for 24 h. RNA was isolated and a NOS cDNA sequence reverse- 
transcribed and amplified  by PCR using the primers described  above. 
The plasmids, pYM3 and pYM4, containing the rat iNOS cDNA 
fragment (266 bp) were made by subcloning the PCIL product in 
antisense (pYM3) and sense (pYM4) directions into the EcoRV site 
under the T7 promoter of the pT7 blue-T vector (Novagen, Inc., 
Madison, WI). The inserts were sequenced  using the dideoxy chain 
termination method (7~q DyeDeoxy Termination Kit; Applied Bio- 
systems, Inc., Foster City, CA) and a DNA sequencer  (model 373A, 
Applied Biosystems, Inc.). tLNA probes were synthesized from the 
linearized plasmids using T7 RNA polymerase and tagged with 
digoxygenin-labeled  UTP  using  a  DIG  RNA  labeling  kit 
(Boehringer Mannheim). 
In Situ Hybridization and Iramunohistocheraistry.  10-/~m  cryostat 
sections of the carotid arteries were adhered to slides coated with 
3-aminopropyltriethoxysilane  (Sigma Chemical  Co., St. Louis, MO), 
and fixed and incubated in prehybridization solution as described 
(25). They were then incubated with the probe at 25 ng/section 
for 16 h at 45~  under coverslips. After hybridization, the cover- 
slips were removed and the sections treated with RNase A followed 
by rinsing with lx SSC and 0.1x SSC at 45~  (25). Sections  were 
then  incubated  with  a  monodonal  antibody  to  digoxygenin 
(Boehringer Mannheim) followed by rabbit anti-mouse immuno- 
globulin,  an alkaline phosphatase-antialkaline phosphatase com- 
plex (Dakopatts, Glostrup, Denmark) and a nitroblue tetrazolium 
substrate solution (25). Immunohistochemical  staining for ~x-smooth 
muscle actin was carried out on 10-/~m cryostat sections using a 
monoclonal antibody (23) followed by avidin-biotin-alkaline  phos- 
phatase detection  (BioGenex, San Ramon,  CA). 
Electron Paramagnetic  Resonance  (EPR) Analysis.  Blood was drawn 
from the carotid artery during catheter surgery and from the heart 
at killing. The samples were frozen in liquid nitrogen and analyzed 
at 77 K on an EPR spectrometer ('Caftan Instruments  Business, 
San Femando, CA) (26). The EPR signals were recorded at a micro- 
wave frequency of 9.17 GHz and a microwave power of 8 mW and 
the spectra were scanned from 3,000 and 3,500 Gauss with a modu- 
lation  amplitude of 8 Gauss and a scan rate of 25 Gauss/rain. 
Results and Discussion 
NOS expression was first analyzed in cultured SMC using 
RT-PCR amplification of a 266 bp fragment from the coding 
sequence of NOS mRNA. No NOS expression was detect- 
able under baseline conditions. It was, however, inducible by 
simultaneous stimulation of  the cells with IFN-qr and TNF-c~ 
(Fig.  1). This PCtL system also amplified constitutive NOS 
sequences from brain (data not shown). Direct sequencing 
was therefore performed on the PCR-amplified 266 bp cDNA 
fragment derived from SMC. It showed complete identity with 
the recently published rat smooth muscle iNOS sequence (8). 
The RT-PCR system was used to analyze NOS expres- 
sion in the rat carotid artery after deendothelializing injury. 
A balloon catheter was used to remove the endothelium and 
intima from a segment of the left common carotid artery, 
and arterial NOS expression during the response to injury 
was analyzed by RT-PCR. Fig. 2 a shows that NOS mRNA 
appeared in the injured artery already at 24 h post surgery. 
These transcripts persisted for 2 wk after surgery (Fig.  2 a). 
Southern hybridization of PCR products with  an iNOS- 
1;igttre 1.  NOS mRNA expression  is induced  in cultured  rat aortic 
SMC by stimulation with IFN-'y and TNF-~ (200 U/ml of each 
for 16 h). RT-PCR, ethidium  bromide-stained  2% NuSieve  agarose 
(FMC Bioproducts,  Rockland,  ME) electrophoresis  gel.  Lane  I, DNA 
ladder; lanes  2-4, three different  SMC cultures treated  with IFN-y 
+  TNF-c~;  lane 5, untreated control SMC. 
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mRNA isoforms in the arterial wall 
after injury. RT-PCR analysis and 
ethidinm-bromide-stained  agarose 
gel (a) and Southern  hybridization 
with an iNOS-specific oligonucle- 
otide  (b)  are  shown.  RT-PCR 
amplification  of 13-actin from the 
same samples is shown for compar- 
ison  (c). Lane I, control without 
template;  lane  2,  uninjured  side, 
24 h after balloon injury; lane 3, in- 
jured side, 24 h after balloon injury; 
lane 4, uninjured side, 3 d after bal- 
loon injury; lane 5, injured side, 3 d 
after balloon injury;  lane 6,  unin- 
jured side, 7 d after balloon injury; 
lane 7, injured  side, 7 d after bal- 
loon injury; lane 8, uninjured  side, 
14 d after balloon injury; lane 9, in- 
jured side, 14 d after balloon injury; 
lane I0, control without template; 
lane 11,  DNA ladder. 
specific antisense oligonucleotide  revealed that NOS mRNA 
of injured arteries  contained iNOS-homologous sequences 
(Fig. 2 b). This shows that the iNOS isoform was induced 
during the response to injury. 
In the uninjured, contralateral artery, a NOS mRNA band 
was detectable at all time points after injury (Fig. 2 a). The 
RT-PCR material obtained 24 h after injury did not hybridize 
with the iNOS-specific oligonucleotide, implying that it rep- 
resented constitutively expressed eNOS (Fig.  2 b). In con- 
trast, bands amplified at subsequent time points contained 
iNOS-like material (Fig. 2 b). It is likely that these RT-PCR 
bands contained a mixture of eNOS and smooth muscle iNOS. 
The latter might have been induced by circulating cytokines 
during the systemic response to injury. 
NOS expressing cells of the lesion were identified by in 
situ hybridization of injured carotid arteries using riboprobes 
transcribed from the pYM3  plasmid that contains the 266 
bp NOS fragment in the antisense direction. Hybridization 
revealed NOt mRNA expression in the cells of the neoin- 
tima (Fig. 3 a). Control hybridization with sense transcripts 
and irrelevant  probes were consistently negative (Fig. 3 b). 
Staining of serial sections with antibodies to monocyte-mac- 
rophages (ED1)  and T  lymphocytes (OX19)  excluded  that 
any significant part of the cells were of hematogenous origin 
(data not shown). Since ,x,98% of the cells in the neointima 
are SMC, the abundant expression of NOt could be attrib- 
uted to  these cells. Staining with or-smooth muscle actin 
confirmed the SMC origin of some of the NOS expressing 
cells (Fig. 3 at). It should, however, be noticed that the majority 
of SMC in the neointima are dedifferentiated and do not ex- 
press oe-smooth muscle actin (27). 
NOS  expression  was  particularly  frequent  among  the 
surface-forming,  pseudoendothelial SMC (Fig.  3).  In con- 
trast, medial SMC were always negative with regard to in 
situ hybridization. In undamaged arterial segments, the en- 
dothelium exhibited a distinctive NOt hybridization signal 
but underlying, medial SMC were NOS negative (Fig. 3 c). 
The preferential  localization of NOt  mRNA  to  surface- 
forming, pseudoendothelial  SMC could result in a high NO 
production at the luminal surface. Since NO inhibits platelet 
aggregation, this could explain the acquisition of nonthrom- 
bogenicity by the pseudoendothelial SMC. 
The difference in NOS expression between medial and neo- 
intimal SMC could be explained by the phenotypic differ- 
ences between the SMC of the two locations, by the pres- 
ence  of inducing  factors  such  as  cytokines  only  in  the 
neointimal compartment, or by inhibitors of NOS expres- 
sion in the media. Our previous detection of monocyte-derived 
macrophages and occasional T lymphocytes in the neointima 
(22, 28) supports a role for NOS-inducing cytokines. It is, 
however,  also possible  that the flow conditions at the vas- 
cular surface provide additional stimuli for NOS expression, 
that the more differentiated,  contractile SMC of the media 
are less responsive to NOS-inducing stimuli, or that the local 
735  Hansson  et al.  Brief Definitive Report Figure  3.  NOS mRNA expression in the postinjury neointima as revealed by in situ hybridization. Dignxygenin-antidigoxygenin-APAAP staining. 
(a) pYM3 antisense hybridization shows hbeling of SMC in neointimal lesion,  original magnification: 250x; (b) sense hybridization is negative,  original 
magnification 250x;  (c) antisense  hybridization, border between lesion  (right)  and uninjured artery (/eft). The junction is indicated  by an arrowhead. 
There is labeling of SMC in the neointima and of endothelium in the uninjured area (arrow), original magnification: 125 x; (d) immunohistochemical 
staining for c~-smooth  muscle actin demonstrates SMC in the injured artery, original magnification:  250x. 
environment of the media inhibits NOS expression.  At any 
extent, SMC-derived NO may act as a paracrine rather than 
autocrine regulator of contractility,  similarly to endothelium- 
derived NO. 
Enzymatic activity of NOS was monitored by EPR anal- 
ysis of nitrosylated hemoglobin (HbNO) in the circulating 
blood from operated rats.  A triplet hyperfine signal charac- 
teristic for nitrosylation of heine groups was detectable after 
injury, culminating after 1 wk (Fig. 4). In contrast, no HbNO 
could be observed in unoperated control rats or in sham- 
operated rats subjected  to arterial  dissection but not deen- 
dothelialization. The HbNO signal was significantly larger 
when the thoracic aorta was deendothelialized compared  with 
the common carotid artery,  indicating that the amount of 
HbNO was proportional to the size of the lesion (Fig. 4). 
The EPR data therefore strongly suggest that at least a sub- 
stantial  part of the circulating HbNO was formed by NO 
released from NOS-expressing neointimal cells. Furthermore, 
they  suggest  that  iNOS  induction in  the  injured artery 
generates  NO in sufficient amounts to nitrosylate proteins 
of circulating erythrocytes, whereas endothelial NOS of in- 
tact arteries do not generate systemically detectable NO (29). 
The difference in their capacity to induce HbNO fits with 
the difference in activity between eNOS and iNOS (1, 2). 
The NO radical is extremely short-lived and reacts with 
other compounds such as proteins within seconds after its 
formation. It is therefore likely that all NO produced in the 
deeper layers of the neointima will react with intra- and ex- 
tracellular molecules in the tissue. The most probable expla- 
nation of the significant  amounts of HbNO complexes in 
circulating erythrocytes is that NO was produced in high 
amounts by the iNOS-expressing pseudoendothelium  at the 
luminal surface. This would permit nitrosylation of hemo- 
globin present in erythrocytes rolling over the injured seg- 
ment. The high degree of oxygenation of arterial blood does 
not exclude that nitrosylation could take place there since 
1-2% of the hemoglobin is not oxygenated and the affinity 
of hemoglobin for NO is 106-fold higher than that for ox- 
ygen (30). 
Several mechanisms could be involved in local iNOS in- 
duction in the neointima. At later time points, i.e.,  7 and 
14 d, it is probable that local expression of IL-1, IFN-3,, and 
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Treatment  Time 
Control 
Carotid  1 day 
injury 
Carotid  3 days 
injury 
Carotid  3 days 
injury 
Aortic  3 days 
injury 
TNF could stimulate iNOS expression. The finding ofiNOS 
expression already at 24 h post injury, i.e.,  at a time point 
when hardly any mononudear cells are present (31, 32), was 
more surprising. One possible explanation is that tissue in- 
jury per se induces iNOS expression,  by releasing preformed 
cytokines or other molecules that could activate the NFKB- 
responsive iNOS promoter (33). Endotoxemia after surgery 
could contribute to the early phase of iNOS expression but 
the finding of iNOS mRNA in the injured but not in the 
uninjured side at 24 h in most of the rats suggests that local 
inducing factors in the response  to injury are more impor- 
tant than systemic ones. 
In conclusion, the results of the present study indicate (a) 
that eNOS mRNA is lost upon deendothdialization of the 
artery; (b) that iNOS mRNA is induced in the injured ar- 
terial segment; (c) that iNOS mRNA expression is localized 
to SMC in the neointima and particularly to the pseudoen- 
dothelial SMC; and (d) that iNOS mRNA expression is as- 
sociated with significant NO production, which is detect- 
able  in the circulation of operated animals.  Together,  the 
present results unveil a homeostatic mechanism that may be 
important for the maintenance of  vascular tone and nonthrom- 
bogenicity, and that depends on the induction of NO produc- 
tion in vascular  smooth muscle cells of the injured artery. 
Figure  4.  EPR detection of HbNO in peripheral blood erythrocytes 
after arterial  injury.  (a) Blood  sample  from  sham-operated  control  rat con- 
tains no HbNO. (b) A triplet hyperfme  signal  representing  HbNO is barely 
detectable I d after deendothelializing  injury to the common  carotid ar- 
tery. (c-d) Significant  triplet hyperfine  I-IbNO signals  are found  3 d after 
carotid injury. (e) An HbNO signal with a larger amplitude  is detected 
3 d after  a larger, deendothelializing  injury  is inflicted  in the thoracic  aorta. 
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